Mumps vaccines are live attenuated viruses. They are known to vary in effectiveness, degree of attenuation and adverse event profile. However, the underlying reasons are poorly understood. We studied two closely related mumps vaccines which originate from the same attenuated Jeryl Lynn-5 strain but have different efficacies. Jeryl Lynn-Canine Kidney (JL-CK), produced on primary canine kidney cells, is less effective than RIT4385, which is produced on chicken embryo fibroblasts. JL-CK and RIT4385 could be distinguished by a number of in vitro and in vivo properties. JL-CK produced heterogeneous, generally smaller plaques than RIT4385, but gave 100-fold higher titres when grown in cells and showed a higher degree of hydrocephalus formation in neonatal rat brains. Sanger sequencing of JL-CK identified 14 regions of heterogeneity throughout the genome. Plaque purification of JL-CK demonstrated the presence of five different Jeryl Lynn-5 variants encompassing the 14 mutations. One JL-CK mutation was associated with a small plaque phenotype, the effects of the others in vitro or in vivo were less clear. Only 4% of the JL-CK population corresponded to the parental Jeryl Lynn-5 strain. Next generation sequencing of JL-CK and virus before and after growth in cell lines or neonatal rat brains showed that propagation in vitro or in vivo altered the population dramatically. Our findings indicate that growth of JL-CK in primary canine kidney cells resulted in the selection of a mixture of mumps virus variants that have different biological properties compared to the parent Jeryl Lynn-5 virus. We also report three previously unknown heterogenic regions within the N gene of the RIT4385 vaccine.

Division of Virology National Institute for Biological Standards and Control Blanche Lane South Mimms Potters Bar Hertfordshire EN6 3QG United Kingdom

Laboratory for Molecular Structure National Institute for Biological Standards and Control Blanche Lane South Mimms Potters Bar Hertfordshire EN6 3QG United Kingdom

State Institute for Drug Control Srobarova 48 10041 Prague 10 Czech Republic

See more in PubMed

Carbone K.M., Rubin S. Mumps virus. In: Knipe D.M., Howley P.M., editors. Fields virology. 5th ed. Lippincott Williams & Wilkins; 2007. pp. 1527–1550.

WHO . WHO; 2007. Weekly epidemiology record; pp. 49–60.

Beck M., Welsz-Malecek R., Mesko-Prejac M., Radman V., Juzbasic M., Rajninger-Miholic M. Mumps vaccine L-Zagreb, prepared in chick fibroblasts. I. Production and field trials. J Biol Stand. 1989;17:85–90. PubMed

Fedova D., Bruckova M., Plesnik V., Slonim D., Sejda J., Svandova E. Detection of postvaccination mumps virus antibody by neutralization test, enzyme-linked immunosorbent assay and sensitive hemagglutination inhibition test. J Hyg Epidemiol Microbiol Immunol. 1987;31:409–422. PubMed

Odisseev H., Gacheva N. Vaccinoprophylaxis of mumps using mumps vaccine, strain Sofia 6, in Bulgaria. Vaccine. 1994;12:1251–1254. PubMed

Sassani A., Mirchamsy H., Shafyi A., Ahourai P., Razavi J., Gholami M.R. Development of a new live attenuated mumps virus vaccine in human diploid cells. Biologicals. 1991;19:203–211. PubMed

Goh K.T. Resurgence of mumps in Singapore caused by the Rubini mumps virus vaccine strain. Lancet. 1999;354:1355–1356. PubMed

da Cunha S.S., Rodrigues L.C., Barreto M.L., Dourado I. Outbreak of aseptic meningitis and mumps after mass vaccination with MMR vaccine using the Leningrad-Zagreb mumps strain. Vaccine. 2002;20:1106–1112. PubMed

Kaic B., Gjenero-Margan I., Aleraj B., Ljubin-Sternak S., Vilibic-Cavlek T., Kilvain S. Transmission of the L-Zagreb mumps vaccine virus, Croatia, 2005–2008. Euro Surveill. 2008;13 PubMed

Brown E.G., Wright K.E. Genetic studies on a mumps vaccine strain associated with meningitis. Rev Med Virol. 1998;8:129–142. PubMed

Gilliland S.M., Jenkins A., Parker L., Somdach N., Pattamadilok S., Incomserb P. Vaccine-related mumps infections in Thailand and the identification of a novel mutation in the mumps fusion protein. Biologicals: J Int Assoc Biol Standardiz. 2013;41:84–87. PubMed

Plotkin S.A., Rubin S.A. Mumps vaccine. In: Plotkin S.A., Orenstein W.A., Offit P.A., editors. Vaccines. 5th ed. Saunders; 2008. pp. 435–465.

Parker L., Gilliland S.M., Minor P., Schepelmann S. Assessment of the ferret as an in vivo model for mumps virus infection. J Gen Virol. 2013;94:1200–1205. PubMed

Tsurudome M., Yamada A., Hishiyama M., Ito Y. Replication of mumps virus in mouse: transient replication in lung and potential of systemic infection. Arch Virol. 1987;97:167–179. PubMed

Houard S., Varsanyi T.M., Milican F., Norrby E., Bollen A. Protection of hamsters against experimental mumps virus (MuV) infection by antibodies raised against the MuV surface glycoproteins expressed from recombinant vaccinia virus vectors. J Gen Virol. 1995;76(Pt 2):421–423. PubMed

Johnson C.D., Goodpasture E.W. An investigation of the etiology of mumps. J Exp Med. 1934;59:1–19. PubMed PMC

Buynak E.B., Hilleman M.R. Live attenuated mumps virus vaccine. 1. Vaccine development. Proc Soc Exp Biol Med. 1966;123:768–775. PubMed

Afzal M.A., Pickford A.R., Forsey T., Heath A.B., Minor P.D. The Jeryl Lynn vaccine strain of mumps virus is a mixture of two distinct isolates. J Gen Virol. 1993;74(Pt 5):917–920. PubMed

Chambers P., Rima B.K., Duprex W.P. Molecular differences between two Jeryl Lynn mumps virus vaccine component strains, JL5 and JL2. J Gen Virol. 2009;90:2973–2981. PubMed PMC

Amexis G., Rubin S., Chizhikov V., Pelloquin F., Carbone K., Chumakov K. Sequence diversity of Jeryl Lynn strain of mumps virus: quantitative mutant analysis for vaccine quality control. Virology. 2002;300:171–179. PubMed

Usonis V., Bakasenas V., Chitour K., Clemens R. Comparative study of reactogenicity and immunogenicity of new and established measles, mumps and rubella vaccines in healthy children. Infection. 1998;26:222–226. PubMed

Plesnik V., Fedova D., Sejda J., Slonim D., Cervenka P., Walderova O. Results of vaccination with Czechoslovakian vaccine against parotitis. Cesk Pediatr. 1984;39:540–546. PubMed

Limberkova R., Lexova P. Genotyping results, laboratory diagnosis, and epidemiology of the mumps virus circulating in the Czech Republic in 2012. Epidemiol, Mikrobiologie, Imunologie: Casopis Spolecnosti Pro Epidemiologii a Mikrobiologii Ceske Lekarske Spolecnosti JE Purkyne. 2014;63:36–42. PubMed

Mrazova M., Smelhausova M., Sestakova Z., Svandova E., Benes C. The 2001 serological survey in the Czech Republic – mumps. Cent Eur J Public Health. 2003;11(Suppl.):S50–S53. PubMed

Stepanova V., Pliskova L., Kosina P., Splino M., Forstl M., Bolehovska R. Mumps – a reemerging infection? The current incidence of mumps in the East Bohemian region in the Czech Republic. Epidemiologie, Mikrobiologie, Imunologie: Casopis Spolecnosti Pro Epidemiologii a Mikrobiologii Ceske Lekarske Spolecnosti JE Purkyne. 2006;55:127–135. PubMed

Boxall N., Kubinyiova M., Prikazsky V., Benes C., Castkova J. An increase in the number of mumps cases in the Czech Republic, 2005–2006. Euro Surveill. 2008:13. PubMed

Afzal M.A., Dussupt V., Minor P.D., Pipkin P.A., Fleck R., Hockley D.J. Assessment of mumps virus growth on various continuous cell lines by virological, immunological, molecular and morphological investigations. J Virol Methods. 2005;126:149–156. PubMed

Schneider C.A., Rasband W.S., Eliceiri K.W. NIH Image to ImageJ: 25 years of image analysis. Nat Methods. 2012;9:671–675. PubMed PMC

Rubin S.A., Afzal M.A., Powell C.L., Bentley M.L., Auda G.R., Taffs R.E. The rat-based neurovirulence safety test for the assessment of mumps virus neurovirulence in humans: an international collaborative study. J Infect Dis. 2005;191:1123–1128. PubMed

Chen R., Vendrell I., Chen C.P., Cash D., O’Toole K.G., Williams S.A. Proteomic analysis of rat plasma following transient focal cerebral ischemia. Biomark Med. 2011;5:837–846. PubMed

Rubin S.A., Pletnikov M., Carbone K.M. Comparison of the neurovirulence of a vaccine and a wild-type mumps virus strain in the developing rat brain. J Virol. 1998;72:8037–8042. PubMed PMC

Afzal M.A., Buchanan J., Heath A.B., Minor P.D. Clustering of mumps virus isolates by SH gene sequence only partially reflects geographical origin. Arch Virol. 1997;142:227–238. PubMed

Malik T.H., Wolbert C., Nerret L., Sauder C., Rubin S. Single amino acid changes in the mumps virus haemagglutinin-neuraminidase and polymerase proteins are associated with neuroattenuation. J Gen Virol. 2009;90:1741–1747. PubMed

Committee on the Safety of Medicines . Committee on the Safety of Medicines; 2002–2015. Advice that unlicensed Pavivac single mumps vaccine should not be imported or used.http://webarchive.nationalarchives.gov.uk/20141205150130/http://www.mhra.gov.uk/home/groups/pl-p/documents/websiteresources/con2031109.pdf

Amexis G., Oeth P., Abel K., Ivshina A., Pelloquin F., Cantor C.R. Quantitative mutant analysis of viral quasispecies by chip-based matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Proc Natl Acad Sci U S A. 2001;98:12097–12102. PubMed PMC

Santak M., Markusic M., Balija M.L., Kopac S.K., Jug R., Orvell C. Accumulation of defective interfering viral particles in only a few passages in Vero cells attenuates mumps virus neurovirulence. Microbes Infect. 2014;17:228–236. PubMed

Ivancic-Jelecki J., Santak M., Forcic D. Variability of hemagglutinin-neuraminidase and nucleocapsid protein of vaccine and wild-type mumps virus strains. Infect Genet Evol. 2008;8:603–613. PubMed

Tanabayashi K., Takeuchi K., Hishiyama M., Yamada A., Tsurudome M., Ito Y. Nucleotide sequence of the leader and nucleocapsid protein gene of mumps virus and epitope mapping with the in vitro expressed nucleocapsid protein. Virology. 1990;177:124–130. PubMed

Rubin S.A., Pletnikov M., Taffs R., Snoy P.J., Kobasa D., Brown E.G. Evaluation of a neonatal rat model for prediction of mumps virus neurovirulence in humans. J Virol. 2000;74:5382–5384. PubMed PMC

Sauder C.J., Vandenburgh K.M., Iskow R.C., Malik T., Carbone K.M., Rubin S.A. Changes in mumps virus neurovirulence phenotype associated with quasispecies heterogeneity. Virology. 2006;350:48–57. PubMed

Sauder C.J., Zhang C.X., Ngo L., Werner K., Lemon K., Duprex W.P. Gene-specific contributions to mumps virus neurovirulence and neuroattenuation. J Virol. 2011;85:7059–7069. PubMed PMC